NewcelX
NCEL----
NewcelX (NCEL)
NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellu...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
NewcelX Analyst Rating
View MoreForecast & Rating
Jul 13, 2026Price forecast
$23.00512.52%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 15 at 08:03 AM
NewcelX wins Brazil patent for NCEL-101 manufacturing process through 2036
- PUBT · Jul 8 at 08:15 AM
NewcelX appoints diabetes researcher Camillo Ricordi to scientific advisory board
- StockTitan · Jul 8 at 12:15 AM
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board | NCEL Stock News
- PUBT · Jul 2 at 01:32 PM
NewcelX reports successful FDA pre-IND meeting for NCEL-101 type 1 diabetes trial plan
- StockTitan · Jul 1 at 12:30 AM
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes | NCEL Stock News
- PUBT · Jun 30 at 03:31 PM
NewcelX holds annual general shareholders meeting
